SG Americas Securities, LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$6,734,000
-0.6%
50,0000.0%0.03%
-11.4%
Q1 2021$6,772,000
-2.5%
50,0000.0%0.04%
-5.4%
Q4 2020$6,949,000
+387.6%
50,000
+486.9%
0.04%
+208.3%
Q2 2020$1,425,000
-88.3%
8,520
-91.0%
0.01%
-89.6%
Q1 2020$12,222,000
+127.3%
95,000
+171.4%
0.12%
+134.7%
Q4 2019$5,377,00035,0000.05%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders